Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low‐hanging fruit meets inconvenient data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low‐hanging fruit meets inconvenient data

Published:2022-05 Issue:5 Volume:20 Page:1067-1069
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Al‐Samkari Hanny^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15675

Reference20 articles.

1. Doxycycline down‐regulates matrix metalloproteinase expression and inhibits NF‐kappaB signaling in LPS‐induced PC3 cells;Ogut;Folia Histochem Cytobiol,2016

2. Novel pharmacological therapy for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia;Jordan;J Vasc Interv Radiol,2015

3. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease;Gaillard;J Thromb Haemost,2014

4. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid – a double‐blind placebo‐controlled cross‐over phase IIIB study;Geisthoff;Thromb Res,2014

5. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia;Faughnan;Ann Intern Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP